193 related articles for article (PubMed ID: 4200340)
1. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
Hanefeld M; Schulze J; Fritz T; Kemmer C
Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
[No Abstract] [Full Text] [Related]
2. [Results of long-term treatment of hyperlipemias].
Reuter W
Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:156-9. PubMed ID: 4200339
[No Abstract] [Full Text] [Related]
3. Long-term treatment of hyperlipidemic patients with clofibrate.
Berkowitz D
JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
[No Abstract] [Full Text] [Related]
4. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
[No Abstract] [Full Text] [Related]
5. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Dimroth H
Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
Loizzi P; Terlizzi N
Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
[No Abstract] [Full Text] [Related]
7. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard].
Schwartzkopff W; Schilling A; Calder D
Med Welt; 1980 Apr; 31(14):515-20. PubMed ID: 7374415
[No Abstract] [Full Text] [Related]
8. [Constellation of lipoproteins in patients with hyperlipoproteinemia and in rabbits fed a cholesterol diet with reference to vascular permeability].
Herrmann W; Reuter W
Z Gesamte Inn Med; 1977 Dec; 32(24):682-2. PubMed ID: 204118
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
Neuman J; de Neuman MP; Talmasky S; Pesce R; Valero E; Martiarena JL
J Cardiovasc Surg (Torino); 1973; Spec No():532-7. PubMed ID: 4377715
[No Abstract] [Full Text] [Related]
10. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
[No Abstract] [Full Text] [Related]
11. [Efficiency of clofibrate in chronic dialysis patients with hyperlipoproteinemia].
Wessels G; Korte R; Lowe H
Med Welt; 1975 Oct; 26(42):1911-3. PubMed ID: 171537
[No Abstract] [Full Text] [Related]
12. A two-year crossover therapeutic trial with halofenate and clofibrate.
Dujovne CA; Azarnoff DL; Pentikainen P; Manion C; Hurwitz A; Hassanein K
Am J Med Sci; 1976; 272(3):277-84. PubMed ID: 797258
[TBL] [Abstract][Full Text] [Related]
13. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
Nordoy A; Gjone E
Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813
[No Abstract] [Full Text] [Related]
14. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
Schwartzkopff W; Hoffmann H; Kästner W
Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
[No Abstract] [Full Text] [Related]
15. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
Krut LH; Seftel HC; Joffe BI
S Afr Med J; 1977 Mar; 51(11):348-52. PubMed ID: 323994
[TBL] [Abstract][Full Text] [Related]
16. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
Huth K; Blumenthal J; Schmahl FW
Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868
[No Abstract] [Full Text] [Related]
17. Polyneuropathy associated with hyperlipemia.
Bechar M; Kott E; Bornstein B
Confin Neurol; 1969; 31(5):281-8. PubMed ID: 5383223
[No Abstract] [Full Text] [Related]
18. [Clinical and therapeutic evaluation of a new antilipemic substance].
de Aguiar Magano L
Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
[TBL] [Abstract][Full Text] [Related]
19. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
Stähelin HB; Hartmann G
Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
[No Abstract] [Full Text] [Related]
20. Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.
Zelis R; Amsterdam EA; Spann JF; Mason DT
JAMA; 1972 Oct; 222(3):326-8. PubMed ID: 4566727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
